Investment
Features
FeesSafety
Academy
More
Pluang+

Two Sophus Capital Emerging Market ETFs to liquidate and cease trading by September 28, 2026

Company Fundamentals
08 Sep 2026
PRNewsWire
View Source
Bearish
Two Sophus Capital Emerging Market ETFs to liquidate and cease trading by September 28, 2026

Empowered Funds, LLC announced the liquidation of two ETFs: Sophus Capital Emerging Market ETF and Sophus Capital Emerging Market Small Cap ETF. Both will stop trading on NASDAQ after September 25, 2026, and will liquidate around September 28, 2026. Shareholders can sell shares before the liquidation date but may face limited market availability. After liquidation, cash proceeds will be distributed to shareholders, which may trigger taxable events. Investors should consult tax advisors regarding implications.

More News

Core Scientific director Elizabeth Crain buys 6,000 shares, signaling confidence in the company.

Core Scientific director Elizabeth Crain buys 6,000 shares, signaling confidence in the company.

Elizabeth Crain, a director at Core Scientific, has purchased 6,000 shares of the company. This insider buying may indicate her confidence in the company's future prospects. Such moves often attract investor attention as they can signal positive expe...

Market News
Bullish
2 hours ago
Hyperscale Data shifts to AI data centers, signals undervaluation and insider confidence

Hyperscale Data shifts to AI data centers, signals undervaluation and insider confidence

Hyperscale Data has stopped Bitcoin mining to focus on AI data center services, backed by a $1.2 billion contract at its Michigan facility. The company's assets, including cash and Bitcoin, are worth nearly double its market cap, suggesting undervalu...

Market News
Bullish
2 hours ago
Casey's General Stores beats Q1 earnings and revenue estimates with 27.1% profit growth.

Casey's General Stores beats Q1 earnings and revenue estimates with 27.1% profit growth.

Casey's General Stores reported strong Q1 2026 results, surpassing analyst expectations with an EPS of $7.37 versus $6.78 estimated and revenue of $5.68 billion beating the $5.56 billion forecast. Net income rose 27.1% year-over-year to $273.7 millio...

Company Fundamentals
Bullish
2 hours ago
Academy Sports to report Q2 2026 earnings with expected revenue growth and higher EPS on Sept 9

Academy Sports to report Q2 2026 earnings with expected revenue growth and higher EPS on Sept 9

Academy Sports and Outdoors will announce its Q2 2026 earnings on September 9, with revenue expected to rise 3.8% year-over-year to about $1.66 billion. Analysts forecast earnings per share between $2.07 and $2.12, up from $1.94 last year, indicating...

Company Fundamentals
Bullish
2 hours ago
Pharvaris stock jumps after positive HAE drug trial and Oppenheimer raises price target to $75

Pharvaris stock jumps after positive HAE drug trial and Oppenheimer raises price target to $75

Pharvaris's experimental oral drug deucrictibant showed an 83% reduction in hereditary angioedema (HAE) attacks in a Phase 3 trial, prompting Oppenheimer to raise its price target from $50 to $75 and maintain an "Outperform" rating. The positive tria...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App